Əsas səhifə

Çap

Əks əlaqə

İnfo
Benzodiazepines for generalized anxiety disorder

Mündəricat

Benzodiazepines for generalized anxiety disorder

Sübutlu məlumatların xülasələri
15.07.2015 • Sonuncu dəyişiklik 15.07.2015
Editors

Benzodiazepines are more effective than placebo for symptom reduction in generalized anxiety disorder, but they cause clinically significant adverse effects.

A topic in Clinical Evidence summarizes the results of one systematic review (search date 1996) including 17 RCTs with a total of 2044 people and 1 subsequent RCT. The systematic review found that benzodiazepines significantly improved symptoms over 2–9 weeks (effect size 0.70, CI not reported) compared to placebo. The subsequent RCT (n=310, comparing 3 interventions) reported response in 73% of patients on diazepam compared to 56% of patients on placebo, p<0.01). RCTs and observational studies found that benzodiazepines increased the risk of dependence, sedation, industrial accidents, and road traffic accidents. Clinical evidence category: Trade off between benefit and harm.

Ədəbiyyat

  1. Gale C, Oakley-Browne M. What are the effects of treatments. Generalized anxiety disorder. Clinical Evidence 2005;13:1279-1290.